Journal of Adolescent Health
Volume 40, Issue 2 , Pages 101-103 , February 2007

Maximizing the Potential Public Health Impact of HPV Vaccines: A Focus on Parents

References 

  1. Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005;6:271–278
  2. Harper DM, Franco EL, Wheeler CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006;367:1247–1255
  3. Goldie SJ, Grima D, Kohli M, et al. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. Int J Cancer. 2003;106:896–904
  4. Munoz N, Bosch FX, Castellsague X, et al. Against which human papillomavirus types shall we vaccinate and screen? (The international perspective). Int J Cancer. 2004;111:278–285
  5. Bergler WF, Gotte K. Current advances in the basic research and clinical management of juvenile-onset recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol. 2000;257:263–269
  6. Little J. 35 million teens missing recommended vaccines. AAP News. 2000;17:81
  7. Schaffner W, Brooks DA, Jenson HB, et al. Adolescent Vaccination: Bridging from a Strong Childhood Foundation to a Healthy Adulthood. Bethesda, MD: National Foundation for Infectious Diseases; 2005;
  8. Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health. 2007;40:108–115
  9. Zimet GD, Liddon N, Rosenthal SL, et al. Chapter 24: psychosocial aspects of vaccine acceptability. Vaccine. 2006;24(suppl 3):S201–S209
  10. Kahn JA, Rosenthal SL, Hamann T, Bernstein DI. Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS. 2003;14:300–306
  11. Olshen E, Woods ER, Austin SB, et al. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health. 2005;37:248–251
  12. Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics. 2006;117:1486–1493
  13. Waller J, Marlow LA, Wardle J. Mothers’ attitudes towards preventing cervical cancer through human papillomavirus vaccination: a qualitative study. Cancer Epidemiol Biomarkers Prev. 2006;15:1257–1261
  14. Brabin L, Roberts SA, Farzaneh F, Kitchener HC. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine. 2006;24:3087–3094
  15. Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis. 2004;8:188–194
  16. Mays RM, Sturm LA, Zimet GD. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med. 2004;58:1405–1413
  17. Zimet GD, Mays RM, Sturm LA, et al. Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Arch Pediatr Adolesc Med. 2005;159:132–137
  18. Williams DR. Racial/ethnic variations in women’s health: the social embeddedness of health. Am J Public Health. 2002;92:588–597
  19. Freeman HP, Wingrove BK. Excess Cervical Cancer Mortality: A Marker for Low Access to Health Care in Poor Communities. Rockville, MD: National Cancer Institute, Center to Reduce Cancer Health Disparities; 2005;May. NIH Pub. No. 05-5282
  20. Krieger N, Quesenberry C, Peng T, et al. Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, Black, Hispanic, and White residents of the San Francisco Bay Area, 1988–92 (United States). Cancer Causes Control. 1999;10:525–537
  21. Shui I, Kennedy A, Wooten K, et al. Factors influencing African-American mothers’ concerns about immunization safety: a summary of focus group findings. J Natl Med Assoc. 2005;97:657–666
  22. Newman PA, Duan N, Rudy ET, Anton PA. Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come?. AIDs Patient Care STDS. 2004;18:691–701

PII: S1054-139X(06)00587-8

doi: 10.1016/j.jadohealth.2006.12.002

Journal of Adolescent Health
Volume 40, Issue 2 , Pages 101-103 , February 2007

Article Tools